Brief: Zyversa Therapeutics Announces Reverse Stock Split & Increase In Authorized Shares Of Common Stock
30/11/2023 16:32
Nov 30 (Reuters) - Zyversa Therapeutics Inc ZVSA.O :
* ZYVERSA THERAPEUTICS, INC. ANNOUNCES REVERSE STOCK SPLIT
AND
INCREASE IN AUTHORIZED SHARES OF COMMON STOCK
* ZYVERSA THERAPEUTICS INC: BOARD OF DIRECTORS HAS APPROVED
A
1-FOR-35 REVERSE STOCK SPLIT OF COMPANY'S COMMON STOCK
* ZYVERSA THERAPEUTICS INC: BOARD APPROVED AN INCREASE IN
COMPANY'S AUTHORIZED SHARES OF CAPITAL STOCK
* ZYVERSA THERAPEUTICS INC: REVERSE STOCK SPLIT WILL BECOME
EFFECTIVE ON DEC 4, 2023 AT 4:01 PM, EASTERN TIME
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Zyversa Therapeutics
See all newsBrief: ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million
Brief: ZyVersa Unveils Potential Of Inflammasome Inhibitors In Combination With GLP-1 Agonists To Address Needs Of People Living With Obesity
Brief: Zyversa Therapeutics Announces Published Data Showing Inflammasome Asc Inhibitor IC 100 Decreases Microglial Inflammasome Activation
Brief: ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative Research And Development Trends For Inflammasome Inhibitors, And Provides Update On Inflammasome ASC Inhibitor IC 100’S Development Status
Brief: Zyversa Therapeutics Files For Prospectus Related To Offer & Resale Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC Filing